Shengbin Pei

674 total citations
24 papers, 321 citations indexed

About

Shengbin Pei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shengbin Pei has authored 24 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Shengbin Pei's work include Ferroptosis and cancer prognosis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and RNA modifications and cancer (6 papers). Shengbin Pei is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and RNA modifications and cancer (6 papers). Shengbin Pei collaborates with scholars based in China, United States and Germany. Shengbin Pei's co-authors include Pengpeng Zhang, Jiaheng Xie, Wei Wang, Jian-Lan Liu, Yiqin Xia, Xiao Zhang, Hui Xie, Fang Yang, Lili Yang and Jun Li and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Breast Cancer Research.

In The Last Decade

Shengbin Pei

20 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengbin Pei China 11 182 138 130 122 90 24 321
Bicheng Ye China 10 177 1.0× 106 0.8× 108 0.8× 147 1.2× 78 0.9× 18 313
Dorothee Franziska Strohmer China 5 174 1.0× 98 0.7× 110 0.8× 100 0.8× 106 1.2× 6 309
Jiaqi Su China 9 194 1.1× 124 0.9× 113 0.9× 135 1.1× 90 1.0× 29 353
Tiening Zhang China 6 168 0.9× 98 0.7× 126 1.0× 70 0.6× 92 1.0× 10 335
Dharmesh D. Bhuva Australia 7 260 1.4× 123 0.9× 114 0.9× 60 0.5× 88 1.0× 12 399
Zhengchun Kang China 6 133 0.7× 176 1.3× 95 0.7× 109 0.9× 163 1.8× 11 358
Eric Kofman United States 9 181 1.0× 100 0.7× 85 0.7× 63 0.5× 77 0.9× 15 342
Wenxian You China 7 167 0.9× 130 0.9× 111 0.9× 110 0.9× 74 0.8× 10 329
Teming Zhang China 6 135 0.7× 160 1.2× 89 0.7× 114 0.9× 110 1.2× 10 324
Autumn L. Jackson United States 4 149 0.8× 140 1.0× 155 1.2× 50 0.4× 121 1.3× 6 355

Countries citing papers authored by Shengbin Pei

Since Specialization
Citations

This map shows the geographic impact of Shengbin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengbin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengbin Pei more than expected).

Fields of papers citing papers by Shengbin Pei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengbin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengbin Pei. The network helps show where Shengbin Pei may publish in the future.

Co-authorship network of co-authors of Shengbin Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Shengbin Pei. A scholar is included among the top collaborators of Shengbin Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengbin Pei. Shengbin Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Xiangyi, Wenxiang Zhang, Xiangyu Wang, et al.. (2025). Tall Cell Carcinoma with Reversed Polarity of the breast: Clinicopathological insights, molecular profile, and future therapeutic directions. The Breast. 82. 104501–104501. 1 indexed citations
2.
3.
Pei, Shengbin, Qiang Liu, Xiangyu Wang, et al.. (2025). Dissecting the tumor microenvironment in primary breast angiosarcoma: insights from single-cell RNA sequencing. Breast Cancer Research. 27(1). 101–101.
4.
Li, Jiajin, et al.. (2025). Pan cancer research reveals the role of PTGDS in tumor suppression and immune regulation. npj Precision Oncology. 9(1). 319–319.
5.
Zhang, Pengpeng, et al.. (2024). Purine metabolism in lung adenocarcinoma: A single‐cell analysis revealing prognostic and immunotherapeutic insights. Journal of Cellular and Molecular Medicine. 28(8). e18284–e18284. 18 indexed citations
6.
Pei, Shengbin, Qiang Liu, Xiangyi Kong, et al.. (2024). Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer. Frontiers in Immunology. 15. 1489444–1489444. 3 indexed citations
7.
8.
9.
Zhong, Hua, Shengbin Pei, Lili Yang, et al.. (2024). Senescence-related genes analysis in breast cancer reveals the immune microenvironment and implications for immunotherapy. Aging. 16(4). 3531–3553. 3 indexed citations
10.
Li, Zhongyan, et al.. (2024). Advancing predictive markers in lung adenocarcinoma: A machine learning‐based immunotherapy prognostic prediction signature. Environmental Toxicology. 39(10). 4581–4593. 5 indexed citations
11.
Xie, Jiaheng, Dan Wu, Shengxuan Liu, et al.. (2023). Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis. Aging. 15(12). 5592–5610. 8 indexed citations
12.
Xie, Jiaheng, et al.. (2023). Digging out the biology properties of tRNA-derived small RNA from black hole. Frontiers in Genetics. 14. 1232325–1232325. 6 indexed citations
13.
Zhang, Pengpeng, Jian-Lan Liu, Shengbin Pei, et al.. (2023). Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq. Frontiers in Immunology. 14. 1189520–1189520. 27 indexed citations
14.
Zhang, Pengpeng, et al.. (2023). The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinoma. Frontiers in Endocrinology. 14. 1154410–1154410. 22 indexed citations
15.
Pei, Shengbin, Pengpeng Zhang, Huilin Chen, et al.. (2023). Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer. Frontiers in Endocrinology. 14. 1135297–1135297. 24 indexed citations
16.
17.
Pei, Shengbin, Pengpeng Zhang, Lili Yang, et al.. (2023). Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. Frontiers in Immunology. 14. 1116839–1116839. 38 indexed citations
18.
Zhang, Pengpeng, Shengbin Pei, Leilei Wu, et al.. (2023). Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma. Frontiers in Endocrinology. 14. 1196372–1196372. 45 indexed citations
19.
Liu, Jian-Lan, et al.. (2023). Liquid-liquid phase separation throws novel insights into treatment strategies for skin cutaneous melanoma. BMC Cancer. 23(1). 388–388. 6 indexed citations
20.
Zhang, Pengpeng, Shengbin Pei, Jian-Lan Liu, et al.. (2023). Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma. Frontiers in Oncology. 12. 1088931–1088931. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bicheng Ye Breakdown of academic impact, for papers by Dorothee Franziska Strohmer Breakdown of academic impact, for papers by Jiaqi Su Breakdown of academic impact, for papers by Tiening Zhang Breakdown of academic impact, for papers by Dharmesh D. Bhuva Breakdown of academic impact, for papers by Zhengchun Kang Breakdown of academic impact, for papers by Eric Kofman Breakdown of academic impact, for papers by Wenxian You Breakdown of academic impact, for papers by Teming Zhang Breakdown of academic impact, for papers by Autumn L. Jackson
Rankless by CCL
2026